Alpha 2.0
Login Register
» Authors » Alejandra Ramirez-Venegas

Alejandra Ramirez-Venegas

Explore the profile of Alejandra Ramirez-Venegas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 1764
Followers 0
Related Specialties
Pulmonary Medicine
General Medicine
Infectious Diseases
Top 10 Co-Authors
Ramces Falfan-Valencia
Raul H Sansores
Gloria Perez-Rubio
Rafael De Jesus Hernandez-Zenteno
Enrique Ambrocio-Ortiz
Rogelio Perez-Padilla
Fernando Flores-Trujillo
Sarbelio Moreno-Espinosa
Beatriz Llamosas-Gallardo
Oliver Perez-Bautista
Published In
Int J Chron Obstruct Pulmon Dis
Salud Publica Mex
Respir Med
PLoS One
Rev Invest Clin
Affiliations
Soon will be listed here.
Recent Articles
1.
Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude
Robles-Hernandez R, Centeno-Saenz G, Ramirez-Venegas A, Thirion-Romero I, Hernandez-Zenteno R, Guinto-Ramirez S, et al.
ERJ Open Res . 2025 Jan; 11(1). PMID: 39872381
Background: COPD ranks as the third leading global cause of mortality. Despite the widespread use of the BODE index and its variants for mortality prediction, their accuracy may be affected...
2.
Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure
Dominguez-de-Barros A, Perez-Rubio G, Fricke-Galindo I, Ramirez-Venegas A, Gajate-Arenas M, Hernandez-Zenteno R, et al.
Respir Res . 2025 Jan; 26(1):23. PMID: 39827100
Background: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow obstruction and destruction of lung tissue, primarily attributed to tobacco smoking. However, other factors like biomass-burning smoke (BS) exposure...
3.
Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass
Ramirez-Venegas A, Montiel-Lopez F, Robles-Hernandez R, Celli B, Sansores R, Cassou-Martinez M, et al.
ERJ Open Res . 2024 Nov; 10(6). PMID: 39588082
Background: COPD due to biomass exposure (COPD-B) is highly prevalent in low- and middle-income countries, and there are no clinical trials designed to evaluate the effectiveness of the treatments currently...
4.
Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
Silva-Gallardo J, Sansores R, Ramirez-Venegas A, Robles Hernandez R, Centeno-Saenz G, Hernandez-Zenteno R
Med Sci (Basel) . 2024 Oct; 12(4). PMID: 39449408
Objective: To measure FeNO levels in patients with COPD-BS and to compare these with those of patients with stable COPD-TS and in healthy controls. Methods: Transversal, observational, descriptive, comparative, and...
5.
Altered levels of IFN-γ, IL-4, and IL-5 depend on the rs4986790 genotype in COPD smokers but not those exposed to biomass-burning smoke
Gutierrez-Romero K, Falfan-Valencia R, Ramirez-Venegas A, Hernandez-Zenteno R, Flores-Trujillo F, Sansores-Martinez R, et al.
Front Immunol . 2024 Aug; 15:1411408. PMID: 39139567
Introduction: Chronic obstructive pulmonary disease (COPD) is associated with tobacco smoking and biomass-burning smoke exposure. Toll-like receptor 4 () single-nucleotide polymorphisms (SNPs) may contribute to its pathogenesis. The study aimed...
6.
Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)
Galindo-Fraga A, Guerra-de-Blas P, Ortiz-Hernandez A, Rubenstein K, Ortega-Villa A, Ramirez-Venegas A, et al.
IJID Reg . 2024 Jul; 12:100394. PMID: 39045384
Objectives: Influenza-like illness (ILI) caused by respiratory viruses results in various respiratory clinical manifestations. The ILI002 prospective observational cohort study aimed to describe viral agents, seasonality, and outcomes of patients...
7.
Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study
Athanazio R, Bernal Villada L, Avdeev S, Wang H, Ramirez-Venegas A, Sivori M, et al.
BMJ Open Respir Res . 2024 Apr; 11(1). PMID: 38637115
Introduction: The cerbations of hronic obstructive lung disease (COPD) and their utcome (EXACOS) International Study aimed to quantify the rate of severe exacerbations and examine healthcare resource utilisation (HCRU) and...
8.
sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant
Fricke-Galindo I, Garcia-Carmona S, Alanis-Ponce J, Perez-Rubio G, Ramirez-Venegas A, Montiel-Lopez F, et al.
Heliyon . 2024 Apr; 10(7):e28675. PMID: 38571598
The receptor for advanced glycation end products (RAGE) and its gene () have been related to lung injury and inflammatory diseases, including chronic obstructive pulmonary disease (COPD). We aimed to...
9.
Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT Study
Aggarwal B, Jones P, Casas A, Gomes M, Juthong S, Litewka D, et al.
Pulm Ther . 2024 Mar; 10(2):183-192. PMID: 38446336
Introduction: Despite the proven benefits of inhaled corticosteroid (ICS)-containing triple therapy for chronic obstructive pulmonary disease (COPD), clinicians limit patient exposure to ICS due to the risk of pneumonia. However,...
10.
Clinical and molecular characterization of children and adults with respiratory bocavirus infection in Mexico: a cross-sectional nested study within the ILI002 prospective observational study
Gamino-Arroyo A, Arellano-Galindo J, Guerra-de-Blas P, Ortega-Villa A, Mateja A, Llamosas-Gallardo B, et al.
Lancet Reg Health Am . 2024 Jan; 29:100647. PMID: 38187006
Background: Human Bocaviruses (HBoV) can cause acute respiratory tract infections. High coinfection rates cloud its pathogenicity. This study sought to describe the clinical features of HBoV1 disease in children and...